causal
Analysis v1
Strong Support
A drug called alirocumab may help prevent serious heart problems and even lower the chance of dying from heart disease in people at high risk — but we’re still not totally sure about the life-extending effects because the data is limited.
59
0
Evidence from Studies
Supporting (1)
59
Community contributions welcome
59
Proprotein convertase subtilisn/kexin type 9 inhibitors and small interfering RNA therapy for cardiovascular risk reduction: A systematic review and meta-analysis
Systematic Review With Meta-Analysis
Human
2023The study looked at Alirocumab and found it cuts the risk of serious heart problems by about 65%, just like the claim says, and also lowers the chance of dying from heart issues or any cause.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.